A study to compare effectiveness of oral Triclofos versus Melatonin for inducing sedation in children for recording EEG in a Tertiary care centre: A Randomised Control Trial
Phase 4
- Conditions
- Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
- Registration Number
- CTRI/2023/10/059031
- Lead Sponsor
- Ananya Pandey
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Provisional diagnosis of Epilepsy, Behavioural disorders, Neurodevelopmental disorders, Learning disabilities, according to DSM 5 Criteria
Exclusion Criteria
1.Patients having significant comorbidities or life threatening conditions
2. Consent to participate not given
3. Patients having adverse reactions to Triclofos or Melatonin
4.Patients having significant respiratory or cardiac disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedation assessed by Richmond Agitation Sedation ScaleTimepoint: 60 min
- Secondary Outcome Measures
Name Time Method Adverse drug reactionTimepoint: 8 hour;Duration of sleepTimepoint: 2 hrs;Interference with EEGTimepoint: 2 hrs